Diabetes mellitus developing in BALB/c ByJ mice infected with the M variant of encephalomyocarditis (EMC) virus is dependent on thymic immune mechanisms. We treated mice with the anti-Tlymphocyte monoclonal anti-L3T4 and anti-Lyt2.2 antibodies before virus inoculation and monitored the infection and occurrence of diabetes thereafter. Mice depleted of L3T4+ cells exhibited a reduced incidence and severity of diabetes compared with both untreated and anti-l_yt2.2-treated animals. All mice sustained pancreatic infections, but islet lesions with p-cell degranulation only occurred in control infected and anti-Lyt2.2-treated animals. These data support the conclusion that the induction of diabetes in EMC-infected BALB/c mice is immune mediated and controlled by the L3T4+ T-lymphocyte subpopulation.
D
iabetes mellitus (DM) develops in certain strains of adult male mice infected with the M variant of encephalomyocarditis (EMC) virus (1) (2) (3) (4) (5) . Recent studies in our laboratory have focused on the mechanism of p-cell injury in two strains of H-2 d mice, the DBA/2 and BALB/c ByJ (1) . In DBA/2 mice, DM appears to result exclusively from direct viral damage to the islets, because it develops in infected thymectomized animals. In contrast, both viral and immunopathological mechanisms are involved in BALB/c mice. Thymectomized, bone marrow-repleted BALB/c mice and those treated with anti-thymocyte serum fail to develop overt DM and sporadically exhibit only mild degrees of hyperglycemia.
The experiments described herein were undertaken to de-fine the contributory roles of the major T-lymphocyte subsets in the disease process. We utilized monoclonal antibodies (MoAbs) directed against helper/inducer (L3T4+) and cytolytic/suppressor (Lyt2.2 + ) T-lymphocytes to deplete mice of specific subset populations before infection (6) . Anti-L3T4-treated mice demonstrated an increased resistance to the development of DM, suggesting a pivotal role for helper/inducer T-lymphocytes in the pathogenesis of the disease and raising interesting questions regarding the immunological mechanisms involved. In this regard, note that MoAb to L3T4 + cells has been shown to inhibit the development of myasthenia gravis (7), autoimmune encephalomyelitis (8) , collagen arthritis (9) , and the lupus syndrome (10) in mice.
MATERIALS AND METHODS
Infection of animals and evaluation of DM. Ten-week-old male BALB/c ByJ mice (Jackson, Bar Harbor, ME) were caged in groups of five or six and maintained in a 12-h light/ dark schedule with food and water ad libitum. The animals were infected by the intraperitoneal inoculation of 30 plaqueforming units (PFU) of EMC virus. The source of this virus and its preparation have been described (5) .
Glucose determinations were done on blood obtained from the retroorbital sinus before and at 7 and 11 days after virus inoculation with a glucose analyzer (Yellow Springs, OH). Glycosuria was monitored with glucose oxidase-impregnated paper strips (Miles, Elkhart, IN). DM is defined as a >2SD increase in blood glucose above the mean of control animals bled and tested simultaneously. Mice were killed at various times, and the viral content of pancreatic and heart tissue was assessed in L929 cells as previously described (5) . Pancreatic tissue was fixed in Bouin's solution and prepared for histological examination with both hematoxylin-eosin and aldehyde-fuchsin stains. MoAb preparation and use. Fluorescein-conjugated (FITC) affinity-purified goat anti-mouse IgG and IgM (Cappel, Cochranville, PA) and FITC-conjugated MoAb directed against rat K-chain (Becton Dickinson, Mountain View, CA) were used. Hybridomas GK1.5 and 2.43 were obtained from Dr. S. Sriram (University of Vermont, Burlington) and were main- tained by intraperitoneal passage in BALB/c CUM mice. The GK1.5 and 2.43 MoAbs recognize the murine L3T4 + and Lyt2.2 + cell subsets, respectively (11, 12) . Ascitic fluid was centrifuged, and the concentration of MoAb in a pool was determined spectrophotometrically after 50% ammonium sulfate precipitation and removal of contaminating albumin. Aliquots were then stored at -20°C. Mice were given 2 mg of either GK1.5, 2.43, or a combination of the MoAbs in a total volume of 0.5 ml on 2 successive days before EMC virus inoculation. Lymphocyte subsets. Mesenteric lymph nodes were washed, and the cells were teased free and resuspended at 1 x 10 7 cells/ml in phosphate-buffered saline containing 1% bovine serum albumin and 0.1% sodium azide (PBS/ BSA). Cells (5 x 10 5 ) in 50 |xl of this solution were incubated at 4°C with an equal volume of a standardized dilution of either anti-L3T4 or anti-Lyt2.2 MoAb. A 1:100 dilution of an FITC-conjugated anti-rat K-MoAb was used as the secondary reagent. Surface immunoglobulin-positive cells were quantified with a 1:100 dilution of an FITC-conjugated goat anti-mouse IgG/IgM mixture in a direct-staining procedure. All samples were thoroughly washed after each incubation step with cold PBS/BSA before fixation with 1% paraformaldehyde. Stained samples were analyzed by flow cytometry with an orthocytofluorograph. Negative control samples were used to gate the analyzer on the basis of forward versus 90° light scatter. Anti-EMC neutralization assay. Mouse serum collected on day 11 after virus inoculaltion was heated (56°C, 30 min), and neutralizing titers were measured with a plaque reduction assay (13) . Approximately 120 PFUs of virus in 0.2 ml were incubated for 60 min at 37°C with an equal volume of diluted jmmune serum. Subsequently, 0.2 ml of this mixture was incubated on L929 cell monolayers, and the lowest dilution of a serum sample resulting in a >50% reduction in PFU was defined as the neutralizing titer. No antibody GK1. 
FIG. 1. Representative islets of Langerhans from mice 12 days after EMC infection stained with either hemotoxylin-eosin (4,C) or aldehydefuchsin (B,D-F). A and B, infected control; C and D, infected anti-L3T4 treated; £, uninfected control; F, infected anti-Lyt2.2 treated. Note lack of insular staining in infected untreated (B) and anti-Lyt2.2-treated (F) mice in contrast to anti-L3T4-treated mice (D). Also, architecture and arrangment of p-cells in infected control animals {A) are dramatically altered compared with infected L3T4-treated mice (C)
. Bar = 50 jim.
RESULTS
Administration of anti-L3T4 MoAb substantially reduced mortality and the incidence of DM during the acute stages of EMC virus infection. MoAbs against Lyt2.2 cells proved ineffectual, and a combination of anti-Lyt2.2 and anti-L3T4 MoAbs yielded results comparable to infected animals treated with anti-L3T4 MoAb alone ( Table 1 ). The severity of the infection in animals of all four treatment groups appeared similar, although the titers of the pancreatic tissue in the antiLyt2.2-treated mice were slightly higher; virus concentrations in the pancreas were maximal 3 days after intraperitoneal inoculation and were still demonstrable after 9 days (Table 2) . Histologically, the islets of infected untreated mice and those administered anti-Lyt2.2 MoAb were shrunken and exhibited degranulation and necrosis of p-cells 11 days after EMC virus inoculation (Fig. 1) . Only slight to moderate evidence of degranulation was seen in an occasional islet of
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mice given anti-L3T4 MoAb. Histochemical staining of (3-cells showed that the insulin granules in the tissue of infected, untreated, and anti-Lyt2.2-treated animals was significantly reduced.
Not all animals treated with anti-L3T4 MoAb were protected against the diabetogenic effects of the virus (Table  1) . A few died, even though T-lymphocytes of this subset in the lymph nodes at day 12 of the infection were significantly reduced. Assays for neutralization antibody in the blood serum of the anti-L3T4-treated mice on day 11 indicated that only animals developing DM raised antibodies against EMC virus. L3T4 + cells are known to play a role in the induction of antibody synthesis by p-lymphocytes.
DISCUSSION
We previously demonstrated the appearance of cells in lymph nodes of EMC-infected BALB/c mice that were cytotoxic for p-cells in culture (14) . It was hypothesized on the basis of this evidence that cytolytic T-lymphocytes play a pathogenic role in EMC-induced DM in this strain of mice. Our findings with animals treated with anti-Lyt2.2 MoAb thus were unexpected and accordingly are of considerable interest. Lyt2.2 + cells might participate in the control of the infection, because animals treated with this antibody had viral tissue titers at intervals after inoculation that were higher than control infected animals. Although enhanced viral replication in the islets of anti-Lyt2.2-treated mice might account for the severity of the islet cell injury in these mice, we believe this is an unlikely explanation. The insular lesions in these mice and infected untreated animals did not differ microscopically.
Several pathogenetic mechanisms for DM in EMC-infected mice have been proposed (1, 4, (15) (16) (17) . Viral damage to the p-cells is intrinsic; in some mouse strains (DBA/2 and SJL) it is sufficient to result in DM. In others, BALB/c ByJ and BALB/c CUM, thymus-dependent immune mechanisms are important in initiating two different metabolic patterns of disease after viral (3-cell damage. In recent studies we have found that in EMC-infected C57BL/6J oblob mice, macrophages appear to play a role in p-cell destruction (unpublished observations).
Adult male BALB/c mice develop DM 5-7 days after virus inoculation. The evidence indicates that the disease results from viral injury to 0-cells complemented by a T-lymphocytemediated pathogenic process. Because p-cell-affected cytolytic T-lymphocytes were found in infected animals, it was thought that these were the effector cells responsible for the lesion (14) . The studies reported herein were undertaken to prove this hypothesis, because anti-Lyt2.2 MoAb has been shown to both deplete Lyt2.2 cells in vivo and inhibit cytotoxic function in vitro (6, 12) . Similarly, anti-L3T4 MoAb treatment causes immunosuppression as a consequence of cell depletion and direct inhibition of cellular function (6, 18) . Humoral immunity (19) and L3T4-mediated cytotoxic function (20) should be suppressed in MoAb-treated mice.
A disquieting aspect of our earlier morphological studies portended the finding summarized above, in that lymphocytic infiltrates were not found in or around the islets of infected mice despite a concerted effort to demonstrate them (J.E.C., G. Babu, and S.A.H., unpublished observations).
Thus, if cytolytic T-lymphocytes were responsible for 3-cell injury, they were only transient residents of the islet and not demonstrable microscopically.
Our findings raise questions regarding the pathogenic mechanisms involved in BALB/c ByJ EMC-induced DM. Could the lesions partly result from T-lymphocyte-mediated antibody production directed at either insulin or the p-cells, or do helper/inducer T-lymphocytes contribute to a delayed hypersensitivity reaction directed against (3-cells? Alternatively, is fJ-cell damage intrinsic to a helper cell-dependent cytolytic T-lymphocyte response? As discussed above, the absence of T-lymphocytes in the insular lesion would argue against the latter possibility. To the best of our knowledge, serious attempts to demonstrate antibodies that react with insulin or p-cell antigens in EMC-infected mice have not been made. However, if antibody is considered an important cofactor in the disease, it is of interest that it acts in most animals by the end of the 1st wk of the infection.
